Skip to main content
Clinical Trials/IRCT20211010052721N1
IRCT20211010052721N1
Recruiting
Phase 3

Evaluation of dexamethasone injection in the middle ear cavity for the treatment of sudden sensorineural hearing loss and comparison with standard methods

Mashhad University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Sudden sensorineural hearing loss.
Sponsor
Mashhad University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with sudden sensorineural hearing loss lasting from 72 hours to less than 30 days after the onset of symptoms
  • Conscious consent to participate in the study

Exclusion Criteria

  • Consumption other medications in addition to prescribed medicationsPregnancy
  • Allergy to prescription drugs
  • Known genetic neurosensory deafness or known anomaly of the inner ear
  • Breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials